Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 15.09B P/E 19.47 EPS this Y 1.70% Ern Qtrly Grth -2.60%
Income 836M Forward P/E 14.84 EPS next Y 8.70% 50D Avg Chg -2.00%
Sales 9.35B PEG 2.73 EPS past 5Y 5.42% 200D Avg Chg -5.00%
Dividend 2.00% Price/Book 2.42 EPS next 5Y 6.37% 52W High Chg -15.00%
Recommedations 2.30 Quick Ratio 0.79 Shares Outstanding 111.32M 52W Low Chg 12.00%
Insider Own 0.43% ROA 6.13% Shares Float 110.39M Beta 0.89
Inst Own 91.50% ROE 13.59% Shares Shorted/Prior 2.42M/2.79M Price 134.76
Gross Margin 33.01% Profit Margin 8.99% Avg. Volume 915,419 Target Price 156.05
Oper. Margin 15.52% Earnings Date Oct 22 Volume 886,819 Change 0.12%
About Quest Diagnostics Incorporated

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

Quest Diagnostics Incorporated News
12/23/24 Quest Diagnostics Upholds Strong Governance and Ethics With Robust Oversight, ESG Integration, and Comprehensive Risk Management
12/20/24 Mainz Biomed partners with Quest for colorectal cancer screening test
12/19/24 Mainz Biomed Forms Agreement with Quest Diagnostics to Provide Clinical Trials Laboratory Services for Colorectal Cancer Screening Test
12/17/24 Quest Diagnostics Advances Environmental Stewardship With Renewable Energy Initiatives, Waste Reduction, and ISO 14001 Certifications in 2023
12/04/24 New Health Coaching Service on questhealth.com Set to Boost DGX Stock
12/03/24 Quest Diagnostics to Speak at the 7th Annual Evercore HealthCONx Conference
12/03/24 Quest Diagnostics Launches Health Coaching on questhealth.com to Help Individuals Take Control of Their Health
11/28/24 Why Quest Diagnostics Incorporated (DGX) Is One of the Most Undervalued Pot Stocks to Buy?
11/27/24 Why Is Encompass Health (EHC) Up 3.8% Since Last Earnings Report?
11/21/24 Quest Diagnostics (DGX) Up 2.7% Since Last Earnings Report: Can It Continue?
11/20/24 Guardant Health Stock Sees RS Rating Jump To 83
11/15/24 SYK Stock Rises Following the Launch of Next Generation SurgiCount+
11/15/24 Quest Diagnostics Incorporated's (NYSE:DGX) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?
11/14/24 GEHC Stock Falls Despite FDA Clearance for SIGNA MAGNUS MRI System
11/13/24 All You Need to Know About Quest Diagnostics (DGX) Rating Upgrade to Buy
11/13/24 Cardinal Health Stock Gains Following Two Strategic Acquisitions
11/13/24 Alcon Q3 Earnings Top Estimates, Margins Up, Stock Gains in Afterhours
11/13/24 Is Quest Diagnostics Stock a Smart Addition to Your Portfolio Now?
11/12/24 Quest Diagnostics Declares Quarterly Cash Dividend
11/12/24 Integer Holdings Gains 40.8% YTD: What's Driving the Stock?
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Doherty Catherine T. SVP, Regional Busine.. SVP, Regional Businesses Mar 03 Sell 140.63 717 100,832 67,810 03/06/23
PREVOZNIK MICHAEL E SVP & General Counse.. SVP & General Counsel Mar 01 Sell 138.54 593 82,154 38,527 03/03/23
Doherty Catherine T. SVP, Regional Busine.. SVP, Regional Businesses Nov 28 Option 86.63 40,765 3,531,472 108,498 11/29/22
Doherty Catherine T. SVP, Regional Busine.. SVP, Regional Businesses Nov 28 Sell 149.14 40,765 6,079,692 67,733 11/29/22
DEPPE MICHAEL J VP, Corp. Controller.. VP, Corp. Controller & CAO Oct 26 Option 54.14 15,497 839,008 47,503 10/27/22
DEPPE MICHAEL J VP, Corp. Controller.. VP, Corp. Controller & CAO Oct 26 Sell 145 15,497 2,247,065 32,013 10/27/22
RING TIMOTHY M Director Director Sep 01 Option 61.23 2,000 122,460 25,933 09/06/22
RING TIMOTHY M Director Director Sep 01 Sell 125.02 2,000 250,040 23,933 09/06/22
Doherty Catherine T. SVP, Group Exec. Cli.. SVP, Group Exec. Clin. Fran. Feb 24 Sell 126.26 2,750 347,215 64,405 02/28/22
PREVOZNIK MICHAEL E SVP & General Counse.. SVP & General Counsel Feb 24 Sell 126.26 1,669 210,728 37,144 02/28/22
WILENSKY GAIL R Director Director Nov 27 Option 57.67 6,111 352,421 22,593 11/27/20
WILENSKY GAIL R Director Director Nov 27 Sell 126.02 6,111 770,108 16,482 11/27/20